133 related articles for article (PubMed ID: 30862142)
1. [Association between the time of neutrophils to the lowest and prognosis of patients with esophageal squamous cell carcinoma treated with non-operative therapy].
Liu S; Huang LP; Lin Z; Liu YF; Zheng ZR; Peng XE; Chen WL; Hu ZJ
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):124-128. PubMed ID: 30862142
[No Abstract] [Full Text] [Related]
2. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy.
Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T
Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415
[TBL] [Abstract][Full Text] [Related]
3. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
4. [The value of the planned neoadjuvant radiotherapy or chemoradiotherapy for the non-radical resection of esophageal squamous cell carcinoma].
Ni WJ; Deng W; Xiao ZF; Zhou ZM; Wang X; Chen DF; Feng QF; Liang J; Lyu JM; Bi N; Deng L; Zhang T; Wang WQ; Xue Q; Gao SG; Mu JW; Mao YS; Wang DL; Zhao J; Gao YS; Huang JF; Tan FW; Zhao L; Lyu F; Zhang GC
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):295-302. PubMed ID: 31014056
[No Abstract] [Full Text] [Related]
5. [The association between the whole blood riboflavin level and the occurrence, development and prognosis of esophageal squamous cell carcinoma].
Li SS; Tan HZ; Xu YW; Wu ZY; Wu JY; Zhao XK; Wang LD; Long L; Li EM; Xu LY; Zhang JJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1124-1129. PubMed ID: 31683399
[No Abstract] [Full Text] [Related]
6. Effect of consolidation chemotherapy following definitive chemoradiotherapy in patients with esophageal squamous cell cancer.
Wu SX; Li XY; Xu HY; Xu QN; Luo HS; Du ZS; Huang HC; Wu ZY
Sci Rep; 2017 Dec; 7(1):16870. PubMed ID: 29203855
[TBL] [Abstract][Full Text] [Related]
7. [The efficacy and safety of high dose versus standard dose radiotherapy in concurrent chemoradiotherapy for patients with esophageal squamous cell carcinoma].
Ren XJ; Wang L; Han C; Liu LL
Zhonghua Zhong Liu Za Zhi; 2019 Feb; 41(2):135-139. PubMed ID: 30862144
[No Abstract] [Full Text] [Related]
8. Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.
Pao TH; Chang WL; Chiang NJ; Chang JS; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
Radiat Oncol; 2020 Sep; 15(1):221. PubMed ID: 32962730
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 and Keap1 abnormalities in esophageal squamous cell carcinoma and association with the effect of chemoradiotherapy.
Zhang J; Jiao Q; Kong L; Yu J; Fang A; Li M; Yu J
Thorac Cancer; 2018 Jun; 9(6):726-735. PubMed ID: 29675925
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma.
Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P
World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of circumferential resection margin in esophageal squamous cell carcinoma after concurrent chemoradiation therapy and surgery.
Liu CY; Wang BY; Lee MY; Tsai YC; Liu CC; Shih CH
J Chin Med Assoc; 2013 Oct; 76(10):570-5. PubMed ID: 23938149
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of NS1-BP expression in esophageal squamous cell carcinoma].
Ren K; Qian D; Wang YW; Pang QS; Zhang WC; Yuan ZY; Wang P
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):21-27. PubMed ID: 29365413
[No Abstract] [Full Text] [Related]
13. Early Recurrence and Cancer Death After Trimodal Therapy for Esophageal Squamous Cell Carcinoma.
Hamai Y; Emi M; Ibuki Y; Murakami Y; Nishibuchi I; Nagata Y; Furukawa T; Kurokawa T; Ohsawa M; Okada M
Anticancer Res; 2019 Mar; 39(3):1433-1440. PubMed ID: 30842179
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Value of the Geriatric Nutritional Risk Index in Patients Exceeding 70 Years Old with Esophageal Squamous Cell Carcinoma.
Wang Y; Wang L; Fang M; Li J; Song T; Zhan W; Xu H
Nutr Cancer; 2020; 72(4):620-626. PubMed ID: 31390885
[TBL] [Abstract][Full Text] [Related]
15. Perioperative change in neutrophil count predicts worse survival in esophageal squamous cell carcinoma.
Song Q; Wu J; Wang S; Xu S
Future Oncol; 2021 Dec; 17(34):4721-4731. PubMed ID: 34431321
[No Abstract] [Full Text] [Related]
16. Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Chen M; Shen M; Lin Y; Liu P; Liu X; Li X; Li A; Yang R; Ni W; Zhou X; Zhang L; Xu B; Lin J; Chen J; Tian Y
Radiat Oncol; 2018 Aug; 13(1):150. PubMed ID: 30111361
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of image-guided radiotherapy for locally advanced esophageal squamous cell carcinoma patients treated with definitive concurrent chemoradiotherapy.
Kuo YH; Fang HY; Lin YS; Lein MY; Yang CY; Ho SC; Li CC; Chien CR
Thorac Cancer; 2020 Jan; 11(1):113-119. PubMed ID: 31742897
[TBL] [Abstract][Full Text] [Related]
18. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the clinical efficacy between single-agent and dual-agent concurrent chemoradiotherapy in the treatment of unresectable esophageal squamous cell carcinoma: a multicenter retrospective analysis.
Li J; Gong Y; Diao P; Huang Q; Wen Y; Lin B; Cai H; Tian H; He B; Ji L; Guo P; Miao J; Du X
Radiat Oncol; 2018 Jan; 13(1):12. PubMed ID: 29357883
[TBL] [Abstract][Full Text] [Related]
20. Associations of ATM Polymorphisms With Survival in Advanced Esophageal Squamous Cell Carcinoma Patients Receiving Radiation Therapy.
Du Z; Zhang W; Zhou Y; Yu D; Chen X; Chang J; Qiao Y; Zhang M; Huang Y; Wu C; Xiao Z; Tan W; Lin D
Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):181-9. PubMed ID: 26094126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
